AQUABOUNTY TECHNOLOGIES INC
Business
AquaBounty Technologies Inc. develops genetically engineered Atlantic salmon for land-based recirculating aquaculture systems (RAS). The company historically pursued grow-out farm operations but has transitioned to asset disposition, selling its Indiana and Canadian farms, intellectual property, and equipment. Its primary remaining asset is the Ohio Farm Project, a partially constructed RAS facility in Pioneer, Ohio, which the company is exploring strategic alternatives to monetize.
Summary from 10-K filed 2026-03-31
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Sales and marketing | 6,613 | 191,299 | 649,568 | 1 | 1 | |
| Research and development | — | 203,296 | 506,243 | 903,981 | 2 | |
| General and administrative | 4 | 9 | 13 | 10 | 9 | |
| Asset impairment, net | — | 190,732 | — | — | — | |
| Total costs and expenses | 4 | 10 | 14 | 25 | — | |
| Operating loss | −4 | −10 | 14 | −22 | −22 | |
| Interest expense | −206,052 | −2 | −234,954 | — | — | |
| Loan forgiveness | 2 | — | — | — | — | |
| Other expense, net | −13,388 | −17,078 | 65,672 | 457,520 | 115,619 | |
| Total other income (expense) | 2 | −2 | −169,282 | 166,343 | −200,823 | |
| Loss from continuing operations | −2 | −11 | 14 | — | — | |
| Loss from discontinued operations | −16 | −138 | 14 | — | — | |
| Net loss | −18 | −149 | 28 | −22 | −22 | |
| Foreign currency gain (loss) | 688,229 | −282,765 | 111,311 | −301,288 | 51,771 | |
| Comprehensive loss | −18 | −149 | 27 | −22 | −22 | |
| Net loss from continuing operation, per share, basic | −0.57 | −2.95 | −3.6 | — | — | |
| Net loss from continuing operation, per share, diluted | −0.57 | −2.95 | −3.6 | — | — | |
| Net loss from discontinued operation, per share, basic | −4.2 | −35.7 | −3.57 | — | — | |
| Net loss from discontinued operation, per share, diluted | −4.2 | −35.7 | −3.57 | — | — | |
| Total basic net loss per share | −4.77 | −38.65 | −7.17 | −5.78 | — | |
| Total diluted net loss per share | −4.77 | −38.65 | −7.17 | −5.78 | −0.32 | |
| Weighted average number of shares outstanding, basic | 4 | 4 | 4 | 4 | — | |
| Weighted average number of shares outstanding, diluted | 4 | 4 | 4 | 4 | 69 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 501,295 | 230,362 | 8 | 102 | 88 | |
| Prepaid expenses and other current assets | 266,862 | 292,018 | 1 | 2 | 2 | |
| Current assets held for sale | 10 | 11 | 22 | — | — | |
| Total current assets | 10 | 11 | 31 | 106 | 193 | |
| Right of use assets, net | 23,000 | 52,000 | 77,877 | 222,856 | 284,320 | |
| Non-current assets held for sale | — | 23 | 11 | — | — | |
| Total assets | 10 | 34 | 188 | 214 | 228 | |
| Accounts payable and accrued liabilities | 337,038 | 893,034 | 12 | 12 | 4 | |
| Accrued employee compensation | 912,103 | 977,088 | 336,409 | 1 | 874,589 | |
| Current debt | — | 1 | 524,462 | 2 | 627,365 | |
| Other current liabilities | 22,982 | 28,527 | 26,368 | 20,830 | 66,269 | |
| Current liabilities held for sale | 7 | 13 | 2 | — | — | |
| Total current liabilities | 9 | 16 | 15 | 15 | 6 | |
| Long-term lease obligations | — | 22,982 | 51,509 | 203,227 | 224,058 | |
| Long-term debt, net | 3 | 2 | 4 | 6 | 9 | |
| Total liabilities | 12 | 18 | 23 | 22 | 15 | |
| Commitments and contingencies (Note 11) | — | — | — | — | — | |
| Common stock, $0.001 par value, 75,000,000 shares authorized; 3,877,695 and 3,865,778 shares issued and outstanding at December 31, 2025 and 2024, respectively | 3,878 | 3,866 | 3,847 | 3,834 | 71,026 | |
| Additional paid-in capital | 386 | 386 | 386 | 385 | 385 | |
| Accumulated other comprehensive loss | — | −688,229 | −405,464 | −516,775 | −255,588 | |
| Accumulated deficit | −388 | −370 | −221 | −193 | −171 | |
| Total stockholders (deficit) equity | −2 | 16 | 165 | 192 | 214 | |
| Total liabilities and stockholders (deficit) equity | 10 | 34 | 188 | 214 | 228 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | — | 904,136 | 2 | 2 | 2 | |
| Share-based compensation | 70,623 | 299,417 | 542,265 | 535,123 | 394,237 | |
| Long-lived asset impairment | 14 | 130 | — | — | — | |
| Loan forgiveness | −2 | — | — | — | — | |
| Other non-cash items | −374,011 | 43,393 | 16,604 | 22,983 | 17,386 | |
| Inventory | — | 2 | 546,847 | −1 | 267,833 | |
| Prepaid expenses and other assets | −141,612 | 1 | 375,430 | −550,120 | −1 | |
| Accounts payable and accrued liabilities | −2 | 614,562 | −50,602 | −1,905 | 230,712 | |
| Accrued employee compensation | −64,985 | 640,679 | −267,119 | 147,151 | 291,288 | |
| Net cash used in operating activities | −9 | −14 | −24 | −21 | −20 | |
| Purchases of and deposits on property, plant and equipment | — | −3 | −69 | −67 | −6 | |
| Proceeds from asset sales | 7 | 10 | — | — | — | |
| Net cash provided by investing activities | 7 | 8 | −69 | 34 | −108 | |
| Proceeds from issuance of debt | 3 | 7 | 417,673 | 476,228 | 606,453 | |
| Repayment of term debt | −1 | −10 | −726,140 | −640,170 | −272,102 | |
| Net cash provided by (used in) financing activities | 2 | −3 | −308,467 | −162,404 | 121 | |
| Effect of exchange rate changes on cash and cash equivalents | 8,769 | −10,133 | 2,827 | 2,748 | 36,152 | |
| Net change in cash and cash equivalents | 270,933 | −9 | −93 | 13 | −7 | |
| Interest paid in cash from continuing operations | — | 2 | 220,125 | 274,562 | 299,056 | |
| Interest paid in cash from discontinued operations | 18,716 | 566,389 | 69,013 | — | — | |
| Non-cash conversion of accounts payable to current debt | 7 | — | — | — | — | |
| Property and equipment included in accounts payable and accrued liabilities | — | 9 | 12 | 11 | 3 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is AQUABOUNTY TECHNOLOGIES INC's CIK number?
AQUABOUNTY TECHNOLOGIES INC's SEC CIK number is 0001603978 (1603978). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find AQUABOUNTY TECHNOLOGIES INC's SEC filings?
All of AQUABOUNTY TECHNOLOGIES INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did AQUABOUNTY TECHNOLOGIES INC last report earnings?
AQUABOUNTY TECHNOLOGIES INC (AQB) most recently filed an earnings 8-K with the SEC on Oct 28, 2025, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001603978-25-000067). This is AQUABOUNTY TECHNOLOGIES INC's most recent earnings filing of record — not a forecast of its next earnings date.
What is AQUABOUNTY TECHNOLOGIES INC's most recent earnings 8-K?
AQUABOUNTY TECHNOLOGIES INC's latest earnings 8-K (Item 2.02) was filed Oct 28, 2025 under accession 0001603978-25-000067. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View AQUABOUNTY TECHNOLOGIES INC's latest earnings 8-K →
Look up any company's CIK number →